Latest News about Cabaletta Bio Inc/
Recent news which mentions Cabaletta Bio Inc/
Lab Notes: Janssen Biotech signs multimillion-dollar cell therapy collaboration and licensing deal
May 05, 2023
Tickers
INNO
From Business Journals
Lab Notes: Imvax advances brain cancer treatment; Wistar identifies promising compound for HIV patients
March 31, 2023
Tickers
INNO
From Business Journals
Lab Notes: Cabaletta signs licensing deal for up to $162M; merger unites life sciences tech providers
October 14, 2022
Tickers
INNO
From Business Journals
Lab Notes: Strata Skin Sciences makes acquisition; Cabaletta Bio promotes 2 executives
January 14, 2022
Tickers
INNO
From Business Journals
Lab Notes: Imvax presents new data on lead drug candidate; Neuronetics forms new partnership
November 12, 2021
Tickers
INNO
From Business Journals